• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON CARIBE LTD. BD BACTEC; PLUS AEROBIC/F CULTURE VIALS; SYSTEM, BLOOD CULTURING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON CARIBE LTD. BD BACTEC; PLUS AEROBIC/F CULTURE VIALS; SYSTEM, BLOOD CULTURING Back to Search Results
Model Number 442023
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problems No Information (3190); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/26/2021
Event Type  malfunction  
Manufacturer Narrative
Multiple lot numbers: there were multiple lot numbers reported to be involved.The information for each lot number is as follows: medical device lot #: 0093305, medical device expiration date: 2021-01-31, device manufacture date: 2020-04-02, medical device lot #: 0283856, medical device expiration date: 2021-07-31, device manufacture date: 2020-10-09, medical device lot #: 0301016, medical device expiration date: 2021-08-31, device manufacture date: 2020-10-27.A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.(b)(4).
 
Event Description
It was reported while performing biofire testing with bd bactec¿; plus aerobic/f culture vials false positive results were obtained for pseudomonas.Two results were reported and two patients were treated.Multiple attempts have been made to obtain additional information, the customer has not responded.
 
Manufacturer Narrative
H6: investigation summary: catalog: 442023, batch no.: 0283856 & 0301016.Customer reported a positive pseudomonas aeruginosa id result for bactec media, while using biofire filmarray® blood culture identification bdic/bcid2 panels.Bd was unable to reproduce the customer¿s experience with the bactec product based on our internal procedures and the intended use of the product.Retention samples were visually inspected, tested for viable contamination by sub-culturing on tsa, chocolate, sabouraud and schaedler agars plates, voltage output and gram stain.All results were satisfactory.Batch history record review did not identify any evidence for which the customer submitted the complaint.Bd bactec system is designed and cleared for the qualitative culture and recovery of anaerobic/aerobic organisms from blood.Bd has no specification for use with molecular testing such as the biofire filmarray® blood culture identification bdic/bcid2 panels.While bd highlights the inherent risk of nonviable organisms in blood culture media in our package insert is stated the molecular tests performed on positive blood cultures will detect both viable and non-viable organisms commonly found in culture media.Therefore, molecular test results should be evaluated in conjunction with gram stain results in accordance with standard-of-care practices as well as manufactures¿ instructions for use.Although bd is unable to confirm the complaint, we have initiated capa # 2631844 to further investigate these reports and determine any appropriate actions to reduce their occurrence.
 
Event Description
It was reported while performing biofire testing with bd bactec¿; plus aerobic/f culture vials false positive results were obtained for pseudomonas.Two results were reported and two patients were treated.Multiple attempts have been made to obtain additional information, the customer has not responded.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD BACTEC; PLUS AEROBIC/F CULTURE VIALS
Type of Device
SYSTEM, BLOOD CULTURING
Manufacturer (Section D)
BECTON DICKINSON CARIBE LTD.
vicks drive
lot no. 6
cayey PR
MDR Report Key11363250
MDR Text Key256809432
Report Number3008352382-2021-00049
Device Sequence Number1
Product Code MDB
UDI-Device Identifier00382904420239
UDI-Public00382904420239
Combination Product (y/n)N
PMA/PMN Number
K113558
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type other,user facility
Type of Report Initial,Followup
Report Date 04/13/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Model Number442023
Device Catalogue Number442023
Device Lot NumberSEE H.10
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 01/29/2021
Initial Date FDA Received02/22/2021
Supplement Dates Manufacturer Received04/13/2021
Supplement Dates FDA Received04/16/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-